KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Mar 22, 2021 $0.0700 $0.0700 $0.0615 $0.0700 3 405
Mar 19, 2021 $0.0651 $0.0719 $0.0649 $0.0700 86 202
Mar 18, 2021 $0.0710 $0.0730 $0.0650 $0.0730 43 230
Mar 17, 2021 $0.0688 $0.0764 $0.0640 $0.0730 86 195
Mar 16, 2021 $0.0615 $0.0764 $0.0615 $0.0760 11 965
Mar 15, 2021 $0.0800 $0.0800 $0.0650 $0.0764 222 349
Mar 12, 2021 $0.0800 $0.0800 $0.0700 $0.0800 55 294
Mar 11, 2021 $0.0895 $0.0895 $0.0650 $0.0800 167 138
Mar 10, 2021 $0.0826 $0.0900 $0.0800 $0.0877 246 460
Mar 09, 2021 $0.100 $0.110 $0.0805 $0.0923 420 036
Mar 08, 2021 $0.0998 $0.110 $0.0965 $0.110 115 136
Mar 05, 2021 $0.110 $0.110 $0.0850 $0.0900 110 554
Mar 04, 2021 $0.116 $0.116 $0.0850 $0.103 140 187
Mar 03, 2021 $0.134 $0.159 $0.0850 $0.135 304 579
Mar 02, 2021 $0.151 $0.159 $0.131 $0.145 50 863
Mar 01, 2021 $0.115 $0.152 $0.115 $0.119 109 515
Feb 26, 2021 $0.109 $0.169 $0.109 $0.109 415 291
Feb 25, 2021 $0.123 $0.123 $0.0850 $0.116 972 188
Feb 24, 2021 $0.170 $0.170 $0.101 $0.116 972 188
Feb 23, 2021 $0.189 $0.189 $0.120 $0.144 420 005
Feb 22, 2021 $0.0840 $0.144 $0.0840 $0.0930 425 493
Feb 19, 2021 $0.0825 $0.109 $0.0825 $0.0930 425 493
Feb 18, 2021 $0.0700 $0.0800 $0.0700 $0.0800 302 432
Feb 17, 2021 $0.0890 $0.0900 $0.0710 $0.0767 393 599
Feb 16, 2021 $0.0600 $0.0867 $0.0580 $0.0867 722 526
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT